The information on this page is based on a number of underlying datasets, most of which are updated monthly. We maintain an update schedule which explains which version of each dataset we are currently relying on.
24 LAVENDER FIELDS is a midsized flat of 80m², built in 2015, which could now be worth an estimated £330,690. It was last sold for £325,000 in July 2017, which was around 79% above the average July 2017 flat price in the Wealden local authority area. The most recent EPC inspection was May 2017, where the current energy rating was C, and the potential energy rating was C.
Land registry data shows one sale for 24 LAVENDER FIELDS since 1st January 1995. The below table shows the price paid for the one sale, along with the average flat price in the Wealden local authority area for the corresponding sale date. The average price is sourced from the Office for National Statistics' House Price Index (HPI).
| Date | Price | HPI Price | Variation from HPI |
|---|---|---|---|
2017 4 JUL | £325,000 | £181,514 | 79% above HPI |
24 LAVENDER FIELDS might now be worth an estimated £330,690.
This is based on house price inflation of 1.8%, between July 2017 and July 2026, for flats, in the Wealden local authority area, as calculated by the Office for National Statistics and published in their UK House Price Index (HPI).
The 1.8% inflationary increase is applied to the most recent sale price for 24 LAVENDER FIELDS of £325,000 on 4th July 2017. For the value to have increased from £325,000 to £330,690 over the nine years to July 2026, the following assumptions must hold true:
24 LAVENDER FIELDS is 80m² according to the EPC inspection conducted in May 2017. This puts it in the smallest 40% of flats in Isfield, based on EPC data. 40% of flats are smaller than 24 LAVENDER FIELDS, and 60% of flats are larger. Note that EPC data is not available for all properties in Isfield.
24 LAVENDER FIELDS sits on a plot of roughly 0.068 of an acre, or 277m².
24 LAVENDER FIELDS is located in ISFIELD, in the TN22 postcode district.
Most recent sales first: